# Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: protocol for a large cluster-randomized implementation study

**Authors:** Shari S. Rogal, Vera Yakovchenko, Timothy R. Morgan, Jason A. Dominitz, Heather McCurdy, Anna Nobbe, Nsikak R. Ekanem, Chaeryon Kang, Rachel I. Gonzalez, Angela Park, Jennifer Anwar, Brittney Neely, Sandra Gibson, Carolyn Lamorte, Jasmohan S. Bajaj, Heather M. Patton, Yiwen Yao, Andrew J. Gawron

PMC · DOI: 10.1186/s13012-025-01448-1 · Implementation Science : IS · 2025-08-09

## TL;DR

This study compares two strategies to improve cancer screening for Veterans, aiming to reduce disparities in liver and colon cancer detection.

## Contribution

The study introduces a large cluster-randomized trial comparing external facilitation and patient navigation for cancer screening implementation.

## Key findings

- The study will evaluate how implementation strategies affect screening completion rates for HCC and CRC.
- It will compare barriers and facilitators in one-time versus repeated screening contexts.
- Results will inform effective implementation approaches for different cancer screening scenarios.

## Abstract

Screening for gastrointestinal (GI) cancers, specifically colorectal cancer (CRC) and hepatocellular carcinoma (HCC), is often inadequately and inequitably implemented, leading to preventable morbidity and mortality. This protocol paper describes a study designed to compare the effectiveness of external facilitation with patient navigation across hospitals in the Veterans Health Administration (VA).

Two hybrid type 3, cluster-randomized trials will compare the effectiveness of patient navigation versus external facilitation for supporting HCC and CRC screening completion. Twenty-four sites will be included in the HCC trial and 32 in the CRC trial, cluster-randomizing Veterans by their site of primary care. The primary outcome of reach of cancer screening completion will be measured after intervention and during sustainment. Multi-level implementation determinants (i.e., barriers and facilitators), preconditions, and moderators will be evaluated pre- and post-intervention, using Consolidated Framework for Implementation Research (CFIR)-mapped surveys and interviews of Veteran participants and provider participants.

Comparing findings in the two trials will allow researchers to understand how implementation barriers and strategies operate differently for a one-time screening in a relatively healthy population (CRC) vs. repeated screening in a more medically complex population (HCC).

This project was registered at ClinicalTrials.Gov (NCT06458998) on 6/13/24.

The online version contains supplementary material available at 10.1186/s13012-025-01448-1.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575), hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Diseases:** HCC (MESH:D006528), gastrointestinal (GI) cancers (MESH:D005770), cancer (MESH:D009369), CRC (MESH:D015179)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12335780/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12335780/full.md

---
Source: https://tomesphere.com/paper/PMC12335780